Nasal DNA-MVA SIV vaccination provides more significant protection from progression to AIDS than a similar intramuscular vaccination. | Mucosal Immunol;2(6): 536-50, 2009 Nov. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Advanced Search EVID@Easy

Nasal DNA-MVA SIV vaccination provides more significant protection from progression to AIDS than a similar intramuscular vaccination.

Manrique, M; Kozlowski, P A; Wang, S-W; Wilson, R L; Micewicz, E; Montefiori, D C; Mansfield, K G; Carville, A; Aldovini, A.

Affiliation

Manrique M; Department of Medicine, Harvard Medical School, Children's Hospital Boston, Boston, Massachusetts, USA.

Mucosal Immunol ; 2(6): 536-50, 2009 Nov.

Article in En | MEDLINE | ID: mdl-19741603

Subject(s)

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Simian Acquired Immunodeficiency Syndrome / SAIDS Vaccines Limits: Animals Language: En Journal: Mucosal Immunol Journal subject: ALERGIA E IMUNOLOGIA Year: 2009 Document type: Article Affiliation country: Country of publication:

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Simian Acquired Immunodeficiency Syndrome / SAIDS Vaccines Limits: Animals Language: En Journal: Mucosal Immunol Journal subject: ALERGIA E IMUNOLOGIA Year: 2009 Document type: Article Affiliation country: Country of publication: